Ashfield UK has appointed David Tweedale and Ian Robinson as business development managers to its commercial and clinical business.
Tweedale joins Ashfield after 11 years at Merz Pharma where more recently he served as sales and marketing manager. He also successfully launched and managed a direct competitor to Botox having joined the business at the beginning of September.
Robinson comes from Bristol-Myers Squibb where he was for 18 years in a number of roles including account manager, regional business director and sales representative. He has been involved in numerous successful launches in both cardiovascular and diabetes products.
Colin Watson, managing director of Ashfield UK, said: “We are thrilled to welcome David and Ian to the business development team. They both bring a great deal of knowledge and experience to our organisation and have joined the business at a very exciting time.”